English

• 13 Apr, 2021
  Årsredovisning 2020
• 26 Mar, 2021
  Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
• 7 Dec, 2020
  Extended SpagoPix patent protection in Europe
• 12 Nov, 2020
  Invitation to webcast
• 12 Nov, 2020
  Distinct images in clinical study with SpagoPix
• 24 Aug, 2020
  Spago Nanomedical appoints candidate drug in the Tumorad® project
• 23 Apr, 2020
  Tumorad[®] patent approval in Japan
• 25 Mar, 2020
  Årsredovisning 2019
• 23 Mar, 2020
  SpagoPix phase I study to next dose level and expansion to additional site
• 9 Jan, 2020
  Lead compound appointed in the Tumorad® -project